在细胞癌中非编码RNA和自之间的交叉声:解读分子通路和治疗前景
Mina Alimohammadi1, Mojgan Noroozi2, Alireza Mafi3,4
1Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Cancer cell international
|September 2, 2025
概括
非编码RNAs (ncRNAs) 调节自,这是一个细胞过程,在癌中具有双重作用. 了解这种相互作用可能会揭示细胞癌 (RCC) 的新诊断生物标志物和治疗点.
科学领域:
- 癌症学
- 分子生物学
- 生物化学
背景情况:
- 细胞癌 (RCC) 是一种侵袭性癌,通常在晚期诊断.
- 传统疗法效果有限,需要新的分子点.
- 细胞降解过程的自,在RCC中起着复杂的作用,同时起到瘤抑制和促进作用.
研究的目的:
- 审查目前对非编码RNAs (ncRNAs) 与细胞癌 (RCC) 自之间的相互作用的理解.
- 确定参与RCC病变的特定ncRNA及其调节机制.
- 评估ncRNA和自作为RCC的诊断生物标志物和治疗点的潜力.
主要方法:
- 对ncRNA,自和RCC的当前知识进行综合的文献综述.
- 对ncRNA调节机制的分析,包括分子海绵,支架和转录调节器的作用.
- 检查自中由ncRNAs调节的信号通路,例如PI3K/AKT/mTOR,AMPK,p53和KEAP1/NRF2.
主要成果:
- ncRNAs,包括长 ncRNAs和微RNAs (miRNAs),是RCC中自的关键调节者.
- 这些ncRNAs影响与自相关的基因表达,并调节关键信号通路.
- ncRNAs可以增强或抑制自活动,影响瘤进展,转移和治疗耐药性.
结论:
- 在RCC的发病过程中,ncRNA与自的交叉交谈至关重要.
- 特定的ncRNA可以作为早期检测和预后的诊断生物标志物.
- 针对ncRNA-自相互作用可能为个性化RCC治疗提供新的治疗策略.
- 对这些分子相互作用的进一步研究可以改善RCC患者的临床结果.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


